Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

Logan C Walker¹, Louise Marquart², John F Pearson³, George A R Wiggins⁴, Tracy A O'Mara⁵, Michael T Parsons⁵; BCFR; Daniel Barrowdale⁶, Lesley McGuffog⁶, Joe Dennis⁶, Javier Benitez⁷, Thomas P Slavin⁸, Paolo Radice⁹, Debra Frost⁶; EMBRACE; Andrew K Godwin¹⁰, Alfons Meindl¹¹, Rita Katharina Schmutzler¹²; GEMO Study Collaborators; Claudine Isaacs¹³, Beth N Peshkin¹³, Trinidad Caldes¹⁴, Frans B L Hogervorst¹⁵; HEBON; Conxi Lazaro¹⁶, Anna Jakubowska¹⁷, Marco Montagna¹⁸; KConFab Investigators; Xiaoqing Chen⁵, Kenneth Offit¹⁹, Peter J Hulick²⁰, Irene L Andrulis²¹, Annika Lindblom²², Robert L Nussbaum²³, Katherine L Nathanson²⁴, Georgia Chenevix-Trench⁵, Antonis C Antoniou⁶, Fergus J Couch²⁵, Amanda B Spurdle⁵

Affiliations

¹ Department of Pathology, University of Otago, Christchurch, New Zealand. logan.walker@otago.ac.nz.
² Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³ Biostatistics and Computational Biology Unit, Department of the Dean, University of Otago, Christchurch, New Zealand.
⁴ Department of Pathology, University of Otago, Christchurch, New Zealand.
⁵ Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁶ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.
⁷ Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
⁸ Department of Population Sciences Division of Clinical Cancer Genomics, City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA, USA.
⁹ Department of Preventive and Predictive Medicine, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.
¹⁰ Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
¹¹ Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
¹² Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany.
¹³ Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
¹⁴ Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
¹⁵ Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁶ Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, Barcelona, Spain.
¹⁷ Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁸ Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
¹⁹ Department of Medicine, Cancer Biology and Genetics, Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²⁰ Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
²¹ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
²² Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
²³ Department of Medicine and Institute for Human Genetics, University of California, San Francisco, CA, USA.
²⁴ Department of Medicine and the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
²⁵ Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

PMID: 30135485
PMCID: PMC6303246
DOI: 10.1038/s41431-018-0216-1

Published Erratum

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

Logan C Walker et al. Eur J Hum Genet. 2019 Jan.

. 2019 Jan;27(1):167-168.

doi: 10.1038/s41431-018-0216-1.

Authors

Affiliations

¹ Department of Pathology, University of Otago, Christchurch, New Zealand. logan.walker@otago.ac.nz.
² Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
³ Biostatistics and Computational Biology Unit, Department of the Dean, University of Otago, Christchurch, New Zealand.
⁴ Department of Pathology, University of Otago, Christchurch, New Zealand.
⁵ Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁶ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.
⁷ Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
⁸ Department of Population Sciences Division of Clinical Cancer Genomics, City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA, USA.
⁹ Department of Preventive and Predictive Medicine, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.
¹⁰ Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
¹¹ Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
¹² Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany.
¹³ Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
¹⁴ Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
¹⁵ Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁶ Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, Barcelona, Spain.
¹⁷ Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁸ Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
¹⁹ Department of Medicine, Cancer Biology and Genetics, Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
²⁰ Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
²¹ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
²² Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
²³ Department of Medicine and Institute for Human Genetics, University of California, San Francisco, CA, USA.
²⁴ Department of Medicine and the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
²⁵ Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

PMID: 30135485
PMCID: PMC6303246
DOI: 10.1038/s41431-018-0216-1

Abstract

This Article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.

PubMed Disclaimer

Erratum for

Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.
Walker LC, Marquart L, Pearson JF, Wiggins GA, O'Mara TA, Parsons MT; BCFR; Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D; EMBRACE; Godwin AK, Meindl A, Schmutzler RK; GEMO Study Collaborators; Isaacs C, Peshkin BN, Caldes T, Hogervorst FB; HEBON; Lazaro C, Jakubowska A, Montagna M; KConFab Investigators; Chen X, Offit K, Hulick PJ, Andrulis IL, Lindblom A, Nussbaum RL, Nathanson KL, Chenevix-Trench G, Antoniou AC, Couch FJ, Spurdle AB. Walker LC, et al. Eur J Hum Genet. 2017 Apr;25(4):432-438. doi: 10.1038/ejhg.2016.203. Epub 2017 Feb 1. Eur J Hum Genet. 2017. PMID: 28145423 Free PMC article.

Publication types

Actions

Grants and funding

20861/CRUK_/Cancer Research UK/United Kingdom

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

Affiliations

Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

Authors

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous